Global Cord Blood Corporation (CO)

Global Cord Blood (CO) Financial Statements


Global Cord Blood Financial Overview

Global Cord Blood's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Global Cord Blood is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement-
Total Revenue-¥ 317.20M¥ 313.67M¥ 315.17M¥ 302.32M
Gross Profit-¥ 269.92M¥ 267.46M¥ 267.33M¥ 256.41M
EBIT-¥ 149.72M¥ 160.45M¥ 156.56M¥ 148.24M
EBITDA-¥ 149.72M¥ 160.45M¥ 156.56M¥ 148.24M
Net Income Common Stockholders-¥ 134.19M¥ 125.74M¥ 136.42M¥ 127.73M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 6.66B¥ 6.51B¥ 6.39B¥ 6.24B¥ 6.08B
Total Assets¥ 1.35B¥ 8.40B¥ 8.26B¥ 8.09B¥ 7.91B
Total Debt¥ 23.00K¥ 1.70M¥ 1.73M¥ 1.75M¥ 1.78M
Net Debt¥ -6.66B¥ -6.50B¥ -6.39B¥ -6.24B¥ -6.07B
Total Liabilities¥ 575.70M¥ 3.61B¥ 3.60B¥ 3.57B¥ 3.52B
Stockholders Equity¥ 769.69M¥ 4.77B¥ 4.64B¥ 4.52B¥ 4.38B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in CNY

Global Cord Blood Earnings and Revenue History

Global Cord Blood Debt to Assets

Global Cord Blood Cash Flow

Global Cord Blood Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis